ATE485286T1 - Tetracyclische steroidderivate als progesteron- rezeptormodulatoren - Google Patents

Tetracyclische steroidderivate als progesteron- rezeptormodulatoren

Info

Publication number
ATE485286T1
ATE485286T1 AT07757092T AT07757092T ATE485286T1 AT E485286 T1 ATE485286 T1 AT E485286T1 AT 07757092 T AT07757092 T AT 07757092T AT 07757092 T AT07757092 T AT 07757092T AT E485286 T1 ATE485286 T1 AT E485286T1
Authority
AT
Austria
Prior art keywords
steroid derivatives
receptor modulators
progesterone receptor
tetracyclic steroid
tetracyclic
Prior art date
Application number
AT07757092T
Other languages
English (en)
Inventor
Ningyi Chen
Nareshkumar F Jain
Zhihua Sui
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE485286T1 publication Critical patent/ATE485286T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT07757092T 2006-02-17 2007-02-16 Tetracyclische steroidderivate als progesteron- rezeptormodulatoren ATE485286T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77434806P 2006-02-17 2006-02-17
PCT/US2007/062280 WO2007098384A2 (en) 2006-02-17 2007-02-16 Tetracyclic steroid derivatives useful as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
ATE485286T1 true ATE485286T1 (de) 2010-11-15

Family

ID=38290140

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07757092T ATE485286T1 (de) 2006-02-17 2007-02-16 Tetracyclische steroidderivate als progesteron- rezeptormodulatoren

Country Status (16)

Country Link
US (1) US7390831B2 (de)
EP (1) EP1996571B1 (de)
JP (1) JP5230451B2 (de)
CN (1) CN101421261B (de)
AT (1) ATE485286T1 (de)
AU (1) AU2007217097B2 (de)
CA (1) CA2642763A1 (de)
CY (1) CY1111110T1 (de)
DE (1) DE602007009945D1 (de)
DK (1) DK1996571T3 (de)
ES (1) ES2353133T3 (de)
HK (1) HK1126475A1 (de)
PL (1) PL1996571T3 (de)
PT (1) PT1996571E (de)
SI (1) SI1996571T1 (de)
WO (1) WO2007098384A2 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2077752B1 (de) * 1970-02-11 1973-03-16 Roussel Uclaf

Also Published As

Publication number Publication date
EP1996571B1 (de) 2010-10-20
HK1126475A1 (en) 2009-09-04
DE602007009945D1 (de) 2010-12-02
CA2642763A1 (en) 2007-08-30
US7390831B2 (en) 2008-06-24
US20070197634A1 (en) 2007-08-23
JP2009527492A (ja) 2009-07-30
SI1996571T1 (sl) 2011-02-28
AU2007217097B2 (en) 2012-12-06
AU2007217097A1 (en) 2007-08-30
CN101421261B (zh) 2013-01-23
CN101421261A (zh) 2009-04-29
CY1111110T1 (el) 2015-06-11
EP1996571A2 (de) 2008-12-03
PT1996571E (pt) 2010-12-07
PL1996571T3 (pl) 2011-04-29
DK1996571T3 (da) 2011-02-07
JP5230451B2 (ja) 2013-07-10
WO2007098384A3 (en) 2007-10-04
ES2353133T3 (es) 2011-02-25
WO2007098384A2 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
ATE453660T1 (de) 17-phosphor-steroid-derivate als progesteron- rezeptormodulatoren
ATE514700T1 (de) Neues tetrazyklisches heteroatom mit als sexualsteroidhormon-rezeptormodulatoren geeigneten derivaten
ECSP088648A (es) Nuevos bencimidazoles 2-sustituidos como moduladores de receptor de androgeno selectivos (sarms)
TW200621725A (en) Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
TW200621235A (en) Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
MX2013002975A (es) Moduladores de receptores de estrogenos y usos de los mismos.
WO2007098381A3 (en) 11-phosphorous steroid derivatives useful as progesterone receptor modulators
MY142850A (en) Novel indole derivatives as selective androgen receptor modulators (sarms)
UA94600C2 (en) Indole sulfonamide modulators of progesterone receptors
TW200624424A (en) Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
TW200604170A (en) Novel indole derivatives as selective androgen receptor modulators (SARMs)
MY143211A (en) Novel indole derivatives as selective androgen receptor modulators (sarms)
PH12014501079A1 (en) 4 - pregenen- 11ss - 17 - 21 -triol-3, 20 -dione derivatives for the treatment of ocular conditions
EA201190236A1 (ru) Новые производные стероидных соединений [3,2-c]пиразолов с глюкокортикоидной активностью
ATE473741T1 (de) Neue imidazolopyrazolderivate als selektive androgen-rezeptor-modulatoren
WO2008109719A3 (en) Steroids derivatives as selective progesterone receptor modulators
ATE485286T1 (de) Tetracyclische steroidderivate als progesteron- rezeptormodulatoren
WO2009140225A3 (en) Anti-inflammatory and immunosuppresive glucocorticoid steroids
WO2007098388A3 (en) Oxa-steroids derivatives as selective progesterone receptor modulators
DE602005010735D1 (de) Neue 2h-chromenderivate als selektive östrogenrezeptor-modulatoren
ATE540953T1 (de) Bizyklische imidazol- oder thiadiazol- heterozyklen als selektive androgen-rezeptor- modulatoren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1996571

Country of ref document: EP